Wealthfront Corp. reported better-than-expected second-quarter 2026 results, with earnings per share of $0.10 versus an analyst estimate of $0.08. Revenue was $91.874 million, ahead of the $91.618 million consensus estimate. Total platform assets rose 12% year over year to $99 billion. The stock gained 6.6% to $10.08 on Thursday as U.S. equities traded lower, with the Dow Jones index down about 250 points. Other notable gainers included Orchestra Biomed Holdings, Clover Health Investments, AeroVironment, Vogenx, Priority Technology Holdings, Pulse Biosciences, Molina Healthcare, Ubiquiti, Centene and PayPay.